Immunome (IMNM)
(Delayed Data from NSDQ)
$14.99 USD
-0.30 (-1.96%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $14.99 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for Immunome, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -106.81 | -36.90 | -24.71 | -17.84 | -10.44 |
Depreciation/Amortization & Depletion | 0.22 | 0.63 | 0.76 | 0.76 | 0.62 |
Net Change from Assets/Liabilities | 12.00 | 2.24 | 2.78 | -1.21 | 0.21 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 87.03 | 5.33 | 2.95 | 6.16 | 0.02 |
Net Cash From Operating Activities | -7.57 | -28.69 | -18.23 | -12.13 | -9.60 |
Property & Equipment | -0.83 | -0.25 | -0.08 | -0.59 | -0.23 |
Acquisition/ Disposition of Subsidiaries | 9.28 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -38.93 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -30.48 | -0.25 | -0.08 | -0.59 | -0.23 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.41 | 0.03 | 28.66 | 55.87 | 4.59 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -0.11 | 0.05 | 6.19 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 116.00 | 0.00 | -0.78 | -5.97 | 0.00 |
Net Cash from Financing Activities | 116.41 | 0.03 | 27.77 | 49.94 | 10.77 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 78.36 | -28.91 | 9.46 | 37.22 | 0.94 |
Cash at Beginning of Period | 20.42 | 49.33 | 39.87 | 2.64 | 1.70 |
Cash at End of Period | 98.78 | 20.42 | 49.33 | 39.87 | 2.64 |
Diluted Net EPS | -5.38 | -3.09 | -2.14 | -5.26 | -9.55 |
Fiscal Year End for Immunome, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -165.61 | -129.49 | -106.81 | -14.17 | -9.83 |
Depreciation/Amortization & Depletion | 0.05 | -0.28 | 0.22 | 0.47 | 0.31 |
Net Change from Assets/Liabilities | 7.35 | 4.48 | 12.00 | 19.92 | 25.77 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 123.65 | 114.11 | 87.03 | 3.67 | 2.26 |
Net Cash From Operating Activities | -34.57 | -11.17 | -7.57 | 9.89 | 18.51 |
Property & Equipment | -4.51 | -2.16 | -0.83 | -0.48 | -0.45 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -20.06 | 9.28 | 0.00 | 0.00 |
Investments | -72.69 | 0.00 | -38.93 | 0.00 | 0.00 |
Other Investing Activities | -41.72 | -15.01 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -118.92 | -37.23 | -30.48 | -0.48 | -0.45 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 234.76 | 233.60 | 0.41 | 0.03 | 0.03 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -14.62 | -14.16 | 116.00 | 60.88 | 0.00 |
Net Cash from Financing Activities | 220.14 | 219.45 | 116.41 | 60.91 | 0.03 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 66.65 | 171.04 | 78.36 | 70.32 | 18.09 |
Cash at Beginning of Period | 98.78 | 98.78 | 20.42 | 20.42 | 20.42 |
Cash at End of Period | 165.43 | 269.82 | 98.78 | 90.74 | 38.52 |
Diluted Net EPS | -0.60 | -2.51 | -4.21 | -0.36 | -0.46 |